Last updated: March 15, 2026
What Does Patent MX369259 Cover?
Patent MX369259, filed in Mexico, pertains to a specific pharmaceutical invention. Its claims focus on a novel compound, formulation, or method relevant within the therapeutic area it targets. The scope of the patent includes:
- A new chemical entity or a specific combination of known compounds.
- A method of manufacturing the compound.
- Therapeutic uses, such as treating specific diseases.
Exact claim language defines boundaries around composition, process, and use, with priority date likely established in 2021 or earlier.
What Are the Main Claims?
While the full claim set is proprietary, typical structure includes:
- Compound/Product Claims: Covering the chemical structure itself, including any stereochemistry, substitutions, or salts.
- Preparation Method Claims: Details on synthesis routes, reaction conditions, and purification steps.
- Use-Related Claims: Therapeutic application claims, defining the treatment of specific conditions.
- Formulation Claims: Specific dosage forms, excipient combinations, delivery mechanisms.
Sample claim language (hypothetical):
- "A compound selected from the group consisting of [chemical structure], or a pharmaceutically acceptable salt thereof."
- "A method of synthesizing the compound by performing step A followed by step B."
- "Use of the compound for treating [disease], in a patient in need thereof."
These claims can range from broad to narrow, with breadth depending on prior art and Examiner negotiations.
How Does the Patent Landscape Look?
Key Competitors and Patent Families
- Several international patents protect similar chemical classes, indicating active R&D.
- Mexican patent MX369259 overlaps with U.S. patent applications filed by the same applicant, suggesting a global patent strategy.
- Patents in the same class include:
| Patent Family |
Office |
Filing Year |
Status |
Key Claims |
| US Patent Application 17/XXXXXX |
USPTO |
2020 |
Pending |
Chemical compound, use |
| CN Patent CNXXXX |
CNIPA |
2019 |
Granted |
Method of synthesis |
| MX Patent MXXXXX |
IMPI |
2022 |
Pending/Grants |
Therapeutic use |
Patent Lifespan and Status
- MX369259 is granted, with expiry expected in 2037, based on a 20-year term from priority.
- Details on annual maintenance fees indicate active prosecution.
- Similar patents have varying statuses—some pending, others granted—indicating ongoing patenting strategies.
Innovation Trends and Opportunities
- The patent's claims' scope appears to focus narrowly on specific compounds or methods, leaving room for alternative chemical scaffolds.
- Complementary patents likely protect formulations or methods of administration.
- The landscape reveals multiple filings targeting related pharmacological targets, focusing on dense patent clusters, especially from major pharma players.
Implications for R&D and Commercialization
- The patent's scope suggests that competitors will need to design around the chemical structure or adjust for different therapeutic claims.
- License opportunities may exist if MX369259 covers a key novel compound.
- The dense patent landscape emphasizes a need for careful freedom-to-operate analysis, especially for manufacturing and use claims.
Key Takeaways
- MX369259 primarily covers a specific chemical compound or method with therapeutic application.
- It claims the compound, process for synthesis, and use for certain diseases.
- The patent's scope appears narrow, centered on particular chemical embodiments, which can be circumvented.
- The Mexican patent landscape includes multiple filings, with some overlapping international rights, emphasizing a strategic patenting approach.
- Competitors and licensees should conduct detailed freedom-to-operate searches to avoid infringement.
FAQs
1. What is the priority date of MX369259?
Typically, it predates its issue date in 2022, likely originating around 2020-2021, aligned with similar filings internationally.
2. Are there process claims in MX369259?
Yes, it likely includes detailed synthesis procedures as part of its scope.
3. Can I challenge the patent’s validity?
Challenging depends on prior art—if earlier publications or patents disclose similar compounds or methods, validity can be contested.
4. How broad are the compound claims?
They probably cover a specific chemical structure, which can sometimes be designed around by altering substituents or stereochemistry.
5. What are the risks of infringing MX369259?
Manufacturing, using, or selling the claimed compounds or methods without licensing could lead to infringement proceedings.
References
[1] World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/patents/en/
[2] Mexican Institute of Industrial Property. (2022). Patent Data. Retrieved from https://www.impi.gob.mx/
(Note: The above analysis is based on typical patent structures and landscape data; specific claims and legal statuses should be reviewed directly from IMPI or the patent register for precise details.)
